Review article · 2025 · Open access

CARing about autoimmune disorders. Use of chimeric antigen receptor engineered T-cells in autoimmune diseases

Adrian-Bogdan Tigu, Mădălina Nistor, Diana Gulei, Catalin-Sorin Constantinescu, Dávid Kegyes, Diana Cenariu, Ximena Maria Mureșan, Raluca Andrada Munteanu, Richard Feder, Ciprian Jitaru, Anamaria Bancos, Maria Santa and 11 more

Blood Reviews, 75, 101354 · Published 26 November 2025 · DOI 10.1016/j.blre.2025.101354

Open full textCite this paper

In brief

“CARing about autoimmune disorders. Use of chimeric antigen receptor engineered T-cells in autoimmune diseases” is a 2025 review article by Adrian-Bogdan Tigu and 22 co-authors, published in Blood Reviews. OpenAlex counts 4 citations as of 19 November 2026, which puts it in the top 3% of works published in 2025 by citations. It is open access under a CC BY licence: the full text is free to read at Blood Reviews.

Citations
4
Most cited in
2026 (4)
Field-weighted impact
0.37
References
351
Authors
23

Abstract

Chimeric Antigen Receptor (CAR) T cell therapy, initially developed for hematologic malignancies, has recently emerged as a promising modality for treating autoimmune diseases. This review explores the evolving role of CAR T cells in reprogramming immune tolerance and achieving durable remission in autoimmune disorders. By engineering T cells to target pathogenic B cells or autoreactive T cells, CAR T therapy offers a targeted and potentially curative approach for diseases such as systemic lupus erythematosus, multiple sclerosis, and type 1 diabetes. Early clinical trials and preclinical models have demonstrated the feasibility, safety, and efficacy of CD19-targeted CAR T cells in depleting autoreactive B cells and restoring immune homeostasis. Furthermore, next-generation CAR designs-including regulatory T cell-based CARs and antigen-specific constructs-highlight the growing precision and versatility of this platform. Despite these advances, challenges remain, including potential toxicity, antigen escape, and the need for long-term immune monitoring. This review summarizes current findings, delineates mechanistic insights, and discusses future directions for optimizing CAR T cell therapies in the context of autoimmunity.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Tigu, A.-B., Nistor, M., Gulei, D., Constantinescu, C.-S., Kegyes, D., Cenariu, D., Mureșan, X. M., Munteanu, R. A., Feder, R., Jitaru, C., Bancos, A., Santa, M., Tomai, R. A., Damian, M., Ivancuta, A., Rus, I., Bojan, A. S., Zdrenghea, M., Buzoianu, A. D., . . . Tomuleasa, C. (2025). CARing about autoimmune disorders. Use of chimeric antigen receptor engineered T-cells in autoimmune diseases. Blood Reviews, 75, 101354. https://doi.org/10.1016/j.blre.2025.101354

MLA 9

Tigu, Adrian-Bogdan, et al. “CARing about autoimmune disorders. Use of chimeric antigen receptor engineered T-cells in autoimmune diseases.” Blood Reviews, vol. 75, 2025, p. 101354. https://doi.org/10.1016/j.blre.2025.101354.

Chicago

Tigu, Adrian-Bogdan, Mădălina Nistor, Diana Gulei, Catalin-Sorin Constantinescu, Dávid Kegyes, Diana Cenariu, Ximena Maria Mureșan, et al. 2025. “CARing about autoimmune disorders. Use of chimeric antigen receptor engineered T-cells in autoimmune diseases.” Blood Reviews 75: 101354. https://doi.org/10.1016/j.blre.2025.101354.

Harvard

Tigu, A.-B. et al. (2025) ‘CARing about autoimmune disorders. Use of chimeric antigen receptor engineered T-cells in autoimmune diseases’, Blood Reviews, 75, p. 101354. doi:10.1016/j.blre.2025.101354.

IEEE

A.-B. Tigu et al., “CARing about autoimmune disorders. Use of chimeric antigen receptor engineered T-cells in autoimmune diseases,” Blood Reviews, vol. 75, p. 101354, 2025, doi: 10.1016/j.blre.2025.101354.

BibTeX

@article{tigu2025caring,
  title     = {{CARing about autoimmune disorders. Use of chimeric antigen receptor engineered T-cells in autoimmune diseases}},
  author    = {Tigu, Adrian-Bogdan and Nistor, Mădălina and Gulei, Diana and Constantinescu, Catalin-Sorin and Kegyes, Dávid and Cenariu, Diana and Mureșan, Ximena Maria and Munteanu, Raluca Andrada and Feder, Richard and Jitaru, Ciprian and Bancos, Anamaria and Santa, Maria and Tomai, Radu Andrei and Damian, Marc and Ivancuta, Andrei and Rus, Ioana and Bojan, Anca Simona and Zdrenghea, Mihnea and Buzoianu, Anca Dana and Tănase, Alina and Einsele, Hermann and Kobold, Sebastian and Tomuleasa, Ciprian},
  journal   = {Blood Reviews},
  year      = {2025},
  volume    = {75},
  pages     = {101354},
  doi       = {10.1016/j.blre.2025.101354},
  url       = {https://doi.org/10.1016/j.blre.2025.101354}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Oncology › CAR-T cell therapy research

  • chimeric antigen receptor T cells
  • CAR T-cell therapy
  • autoimmune disease
  • immune tolerance
  • systemic lupus erythematosus
  • multiple sclerosis
  • type 1 diabetes
  • CD19 CAR T cells

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Tigu, A.-B., Nistor, M., Gulei, D., Constantinescu, C.-S., Kegyes, D., Cenariu, D., Mureșan, X. M., Munteanu, R. A., Feder, R., Jitaru, C., Bancos, A., Santa, M., Tomai, R. A., Damian, M., Ivancuta, A., Rus, I., Bojan, A. S., Zdrenghea, M., Buzoianu, A. D., . . . Tomuleasa, C. (2025). CARing about autoimmune disorders. Use of chimeric antigen receptor engineered T-cells in autoimmune diseases. Blood Reviews, 75, 101354. https://doi.org/10.1016/j.blre.2025.101354

How many times has this paper been cited?

4 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Blood Reviews: sign in and open the full text from this page.

Who wrote this paper?

Adrian-Bogdan Tigu, Mădălina Nistor, Diana Gulei, Catalin-Sorin Constantinescu, Dávid Kegyes, Diana Cenariu, Ximena Maria Mureșan, Raluca Andrada Munteanu, Richard Feder, Ciprian Jitaru, Anamaria Bancos, Maria Santa and 11 more.

What is the DOI of this paper?

10.1016/j.blre.2025.101354, permanently at https://doi.org/10.1016/j.blre.2025.101354. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.